Login To Trade  |  About IIFL
  • NIFTY  6976.35  -239.35 -3.32%
  • SENSEX 22951.83  -807.07 -3.4%
  1. News
  2. Sector

  3. Pharma & Healthcare

Covidien to buy Somanetics

India Infoline News Service | Mumbai | June 16, 2010 17:06 IST

The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.

Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.






Get the most detailed result analysis on the web - Real Fast!

Actionable & Award-Winning Research on 500 Listed Indian Companies.

Read more on: Covidien  to  buy  Somanetics   
article
113101301220
Covidien to buy Somanetics
Covidien to buy Somanetics
The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.
http://www.indiainfoline.com/article/news-sector-pharma-healthcare/covidien-to-buy-somanetics-113101301220_1.html
June 16, 2010 17:06 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Covidien to buy Somanetics
Pharma & Healthcare
$rawVideoFileUrl$
$videoPlayerUrl$

Download IIFL Markets App